| Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273) |
|---|
| 01/29/2009 | WO2009012609A1 Amide addition reaction |
| 01/29/2009 | WO2008107211A3 Novel p2y12 receptor antagonists |
| 01/29/2009 | WO2008049595A9 Trypsin-like serine protease inhibitors, and their preparation and use |
| 01/29/2009 | WO2007144769A8 Aryl- and heteroaryl-ethyl-acylguanidine derivatives, their preparation and their application in therapeutics |
| 01/29/2009 | US20090030209 (1S,2S,3R,4S,5R,8R,9S,10R,13S)-4-Acetoxy-2-benzoyloxy-5,20-epoxy-1,13-dihydroxy-9,10-[(1S)-2-propenylidenedioxy]tax-6,11-diene; antitumor compounds; using low toxic and inexpensive materials; product is readily purified; industrial production |
| 01/29/2009 | US20090030047 Peritoneum protecting agent |
| 01/29/2009 | US20090030042 Amide Addition Reaction |
| 01/29/2009 | US20090030010 3-Amino-pyrazolo[3,4b]pyridines as inhibitors of protein tyrosine kinases, their production and use as pharmaceutical agents |
| 01/29/2009 | US20090029995 Hetero biaryl derivatives as matrix metalloproteinase inhibitors |
| 01/29/2009 | US20090029994 Trisubstituted amine compound |
| 01/29/2009 | US20090029991 Benzamide derivatives useful as histone deacetylase inhibitors |
| 01/29/2009 | US20090026930 Aromatic compound, organic light-emitting diode including organic layer including the aromatic compound, and method of manufacturing the organic light-emitting diode |
| 01/29/2009 | CA2697166A1 Isophthalamide derivatives inhibiting betasecretase activity |
| 01/28/2009 | EP2019091A1 Novel polyhydroxylated compounds as Fatty Acid Synthase (FASN) inhibitors |
| 01/28/2009 | EP2019090A1 Substituted beta-phenyl-alpha-hydroxy propanoic acid, synthesis method and use thereof |
| 01/28/2009 | EP2018367A1 Novel microbiocides |
| 01/28/2009 | EP2018364A1 Therapeutic fluoroethyl ureas |
| 01/28/2009 | EP0966443B1 Heteroaryl-hexanoic acid amide derivatives, their preparation and their use as selective inhibitors of mip-1-alpha binding to its ccr1 receptor |
| 01/28/2009 | CN101356170A Heterocyclic modulators of ATP-binding cassette transporters |
| 01/28/2009 | CN101356163A Sulfanyl substituted phenyl methanones as glycine transporter 1 (GlyT-1) inhibitors for the treatment of neurological and neuropsychiatric disorders |
| 01/28/2009 | CN101356155A Phenoxy acetic acids as PPAR-delta activators |
| 01/28/2009 | CN101353322A Method for preparing nicotinic acid by pyridine dicarboxylic acid non-catalysis decarboxylation in high temperature liquid water |
| 01/28/2009 | CN100455569C Novel pyrithione complex compound, process for producing the same and use thereof |
| 01/28/2009 | CN100455566C Novel derivatives of aminocyclohexane |
| 01/28/2009 | CN100455564C Histone de-acetylase inhibitor, preparation and application of pharmaceutical preparations of the same |
| 01/27/2009 | US7482466 Hydroxamates as therapeutic agents |
| 01/27/2009 | US7482464 in dimethyl sulfoxide from (R,S)-amlodipine on an industrial scale using L-(+)-tartaric acid which is much cheaper than D-(-)-tartaric acid; (S)-(-)-amlodipine-hemi-L-tartrate-1/4-DMSO-solvate claimed |
| 01/27/2009 | US7482462 Immunosuppressants for treating skin disorders, acne, alopecia, estrogen- or androgen-dependent tumors, rheumatoid arthritis, type I and II diabetes, lupus erythematosus, multiple sclerosis, ulcerative colitis, Crohn's disease, psoriasis, contact dermatitis, graft versus host disease, eczema, asthma |
| 01/27/2009 | US7482452 intermediates for p38 MAP kinase inhibitors; industrial scale; 3-cyano-6-oxo-2-thio-1,6-dihydropyridines or pyrimidine, 2,4-diones as starting reactants and 2-cyano-N-phenylthioacetamide; cyclization; diazotization of 3-amino-7H-thieno[2,3-b]pyridin-6-ones, halide displacement |
| 01/27/2009 | US7482369 Anthranilic acid amides and their use as VEGF receptor tyrosine kinase inhibitors |
| 01/27/2009 | US7482366 Modulators of LXR |
| 01/27/2009 | US7482364 Histamine H3 antagonists; do not contain imidazolyl moiety; such as 1-[4-(4-piperidin-1-ylmethyl-phenyl)-but-3-ynyl]-piperidine |
| 01/27/2009 | US7482357 N-(pyridin-2-ylmethyl)-4-methyl-3-oxo-4-aza-5 alpha -androst-1-en-17 beta -acetamide; enhancement of weakened muscle tone; osteoporosis, bone disorders; ; periodontal disease, frailty, aging skin, male hypogonadism, postmenopausal symptoms, inflammatory arthritis, cachexia, Alzheimer's disease |
| 01/27/2009 | US7482348 Piperazinyl substituted cyclohexane-1,4-diamines |
| 01/27/2009 | US7482340 Pyridine derivatives useful for inhibiting sodium/calcium exchange system |
| 01/27/2009 | CA2380757C Pharmaceutical agent comprising a benzamide derivative as active ingredient |
| 01/27/2009 | CA2346796C Benzoylcyclohexanediones, process for their preparation and their use as herbicides and plant growth regulators |
| 01/27/2009 | CA2247443C Substituted 4-hydroxy-phenylalcanoic acid derivatives with agonist activity to ppar-gamma |
| 01/27/2009 | CA2206238C Alkylidenehydrazinophenylsulfonylureas, processes for their preparation and their use as herbicides and plant growth regulators |
| 01/22/2009 | WO2009012283A1 Compounds and methods for kinase modulation, and indications therefor |
| 01/22/2009 | WO2009011674A1 Trans-1,2-diphenylethylene derivatives and nanosensors made therefrom |
| 01/22/2009 | WO2009011305A1 Amide compound and method for controlling plant disease using the same |
| 01/22/2009 | WO2009011285A1 Heteroarylbenzene compounds |
| 01/22/2009 | WO2009010660A2 Substituted indazoles, the preparation thereof, and use of same in therapeutics |
| 01/22/2009 | WO2009010522A1 Aldimines and compositions comprising aldamine |
| 01/22/2009 | WO2009010454A2 Amido derivatives and their use as positive allosteric modulators of metabotropic glutamate receptors |
| 01/22/2009 | WO2009010296A2 Antibodies against 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and metabolites thereof |
| 01/22/2009 | WO2009010156A2 Substituted phenylpropoargyl compounds, methods for the production thereof, and use of same as herbicides and plant growth regulators |
| 01/22/2009 | WO2008052737A3 Immunochemically equivalent hiv drug analogs |
| 01/22/2009 | US20090024096 Immobilization of dyes and antimicrobial agents on a medical device |
| 01/22/2009 | US20090023927 Process for producing tricyclic ketone |
| 01/22/2009 | US20090023923 1-(4-Bromo-3-methyphenyl)-3-(3,5-dichlorophenyl)-3-hydroxy-4,4,4-trifluorobutane-1-one; -(4-Bromo-3-methylphenyl)-3-(3,5-dichlorophenyl)-4,4,4-trifluoro-2-butene-1-one; chemical intermediates for agricultural pesticides, insecticides |
| 01/22/2009 | US20090023921 such as dibenzoyl-L-tartaric acid salt of 1-cyclopentyl-3-(2,6-diethylpyridin-4-yl)propan-1-one |
| 01/22/2009 | US20090023918 Process for preparing 3-acylaminobenzofuran-2-carboxylic acid derivative |
| 01/22/2009 | US20090023787 Technetium-dipyridine complexes, and methods of use thereof |
| 01/22/2009 | US20090023786 Histone Deacetylase Inhibitor Prodrugs |
| 01/22/2009 | US20090023785 6-substituted nicotinamide derivatives as opioid receptor antagonists |
| 01/22/2009 | US20090023763 Condensed Pyridine Derivatives Useful as A2B Adenosine Receptor Antagonists |
| 01/22/2009 | US20090023747 Cysteine Protease Inhibitors |
| 01/22/2009 | US20090023735 Sulphonamide Derivatives |
| 01/22/2009 | US20090023734 Treating cell proliferative disorders |
| 01/22/2009 | US20090023730 such as 1-(3-tert-butyl-1-methyl-1H-pyrazole-5-carbonyl)-3-(4-(pentyloxy)-3-(trifluoromethyl)phenyl)thiourea; packages, patches; hepatitis virus infections |
| 01/22/2009 | US20090023664 protease inhibitors such as 5-(dimethylamino)-N-[(2S,3R)-3-hydroxy-4-[(4-methoxyphenyl)sulfonyl-(2-methylpropyl)amino]-1-phenylbutan-2-yl]-2-methylbenzamide, used for for treating human immunodeficiency virus (HIV) infections |
| 01/22/2009 | CA2695004A1 Compounds and methods for kinase modulation, and indications therefor |
| 01/21/2009 | EP2017276A1 Phenyl-carboxamide compounds useful for treating pain |
| 01/21/2009 | EP2017266A1 Pyridazine derivatives and medicines containing the same as effective ingredients |
| 01/21/2009 | EP2017264A1 Substituted phenyl propargyl compounds, method for their manufacture and their use as herbicides and plant growth regulators |
| 01/21/2009 | EP2017260A1 Aldimines and compounds containing aldimine |
| 01/21/2009 | EP2016954A1 Antibodies against 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and metabolites thereof |
| 01/21/2009 | EP2016086A2 Methods of nanoassembly of a fractal polymer and materials formed thereby |
| 01/21/2009 | EP2016084A2 Process for the preparation of pure risedronic acid or salts |
| 01/21/2009 | EP2016069A1 Bis-pyridinium compounds |
| 01/21/2009 | EP2016055A1 Inhibitors of p38 map kinase |
| 01/21/2009 | EP2016054A2 Derivatization-enhanced analysis of amino acids and peptides |
| 01/21/2009 | EP2015848A1 2, 3, 4, 6-substituted pyridines and their use as hair dyeing compositions |
| 01/21/2009 | EP1501791B1 Amino acid analogues |
| 01/21/2009 | CN101351450A Metal complex compound and organic electroluminescent device using same |
| 01/21/2009 | CN101348487A Preparation of multi-sulfonic functional ion liquid |
| 01/21/2009 | CN101348461A N-(3-pyridine formyloxy)-3,5-dimethyl-1-amantadine for curing senile dementia or pharmaceutical salt thereof |
| 01/21/2009 | CN101348460A Substituted furan (pyridine, pyrazole) formamide tertiary butyl thiacetic mulin ester |
| 01/21/2009 | CN101348459A Preparation of sulfide-containing metal complex |
| 01/21/2009 | CN101348455A Aspartic acid specificity cysteine proteinase inhibitors and uses thereof |
| 01/21/2009 | CN101348448A Preparation of ion liquid having B acid center and L acid center |
| 01/21/2009 | CN101347744A Catalyst for synthesizing pyridine using microsphere type high-silicon ZSM-5 molecular sieve as carrier and preparation method thereof |
| 01/21/2009 | CN100453529C Aryl sulfonamides and analogues thereof and their use in treatment of neurodegenerative diseases |
| 01/21/2009 | CN100452984C Aimal growth regulating composition and its prepn and use |
| 01/20/2009 | US7479573 Cationic lipids capable of facilitating transport of biologically active agents or substances into cells; lipid aggregate macromolecular complex interacts with cells making the polyanionic macromolecule available for absorption and uptake by the cell |
| 01/20/2009 | US7479491 Azanthranylalkyl and -cycloalkyl amides and their use as VEGF receptor inhibitors |
| 01/20/2009 | CA2502856C Intermediates for retroviral protease inhibiting compounds |
| 01/20/2009 | CA2351693C Synthesis of intermediates useful in preparing tricyclic compounds |
| 01/20/2009 | CA2337770C Amide derivatives which are useful as cytokine inhibitors |
| 01/20/2009 | CA2214531C Treatment of cytokine growth factor caused disorders |
| 01/15/2009 | WO2009008769A1 Oxalate n,n-dimethyl-2-n,n-dimethylaminomethylpyridyl-3-carbomate exhibiting anti-cholinesterase activity and improving cognitive functions |
| 01/15/2009 | WO2009008353A1 Chrysene derivative and organic el device |
| 01/15/2009 | WO2009007415A2 Novel compounds |
| 01/15/2009 | WO2009007396A1 Nonsteroidal progesterone receptor modulators |
| 01/15/2009 | WO2009007015A1 Malonamide derivatives with antithrombotic activity |
| 01/15/2009 | WO2008128622A3 Pyridine compounds for liquid-crystalline mixtures |
| 01/15/2009 | WO2008101914A3 N-adamantyl benzamides as inhibitors of 11-beta-hydroxysteroid dehydrogenase |
| 01/15/2009 | WO2008077170A3 Benzothioamides, and use thereof for relaxing smooth muscles |